Pharma News, Research & Solutions

Our efforts to reduce carbon emissions were acknowledged in 2016 with our inclusion in the ‘Climate A List’. CDP assessed companies globally from across 10 industry sectors; we were one of only 193 companies (9% of applicants) and seven healthcare companies to be A-listed.

As we learn more about how sustainable building techniques can be used for industrial purposes, we are putting this knowledge into practice with similar projects in the UK, where GSK funding led to the construction of the country’s first ever carbon neutral laboratory in Nottingham.

Our pharmacovigilance centre of excellence collects publically available data from social media and filters out unrelated information and anything that would infringe patient privacy. The Centre’s analysis is helping us to understand the benefits of our products, alert us to unexpected adverse effects, and evaluate the misuse of drugs.

In 2016, we topped the Access to Medicine Index for the fifth consecutive time since it began in 2008. The index is an independent measure of the top 20 pharmaceutical companies’ efforts to improve access to healthcare in developing countries.

Shire plc (LSE: SHP, NASDAQ: SHPG) today announced the launch of the Company’s 2016 Annual Responsibility Review. The Review, available at shire.com, highlights how Shire’s growth has strengthened its approach to Responsibility and allows the Company to better meet the needs of people around the world with rare diseases and their families.

By being commercially successful and operating responsibly, we will improve people’s health and benefit society, as well as create value for shareholders.

Resistance to antibiotics is a major public health crisis, with 700,000 people dying every year from drug resistant infections. We have 70 years of expertise in antibiotics and we’re committed to continuing our research in this area.

Today, Pfizer launched its 2016 Annual Review, which provides an in-depth look at how the company is working to accelerate patient impact. The report provides an overview of the company’s financial, social and environmental performance throughout last year.

Sandoz, a Novartis Division, announced today the three winners of the inaugural Healthcare Access Challenge (Sandoz HACk). The winners, chosen by a panel of judges at the Wired Health 2017 event in London, identified innovative approaches to address challenges in Ghana, the Maldives and the Philippines.

On March 10, the LIVESTRONG Foundation will host an unveiling reception for The Hero’s Journey Art, an art installation created by sculptor John Magnan.